The use of solution calorimetry with micellar solvent systems for the detection of polymorphism

International Journal of Pharmaceutics

Volumn 231, Issue 2, 2002, Pages 185-196

  Souillac, Pierre O ^a   Dave, Pankaj ^b   Rytting, J Howard ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b Invamed Inc   (United States)

Author keywords

Polymorphism; Solution calorimetry; Surfactants

Indexed keywords

CIMETIDINE; DODECYL SULFATE SODIUM; POLYSORBATE 20; SURFACTANT;

ARTICLE; CALORIMETRY; DISSOLUTION; DRUG DETERMINATION; ENTHALPY; INFRARED SPECTROSCOPY; MEASUREMENT; MELTING POINT; MICELLE; MICROSCOPY; PRIORITY JOURNAL; WETTABILITY; X RAY POWDER DIFFRACTION;

CALORIMETRY; CIMETIDINE; HISTAMINE H2 ANTAGONISTS; POLYMORPHISM, GENETIC; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; X-RAY DIFFRACTION;

EID: 0037074099     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00877-8     Document Type: Article

References (49)

1. Polymorphic transitions of cimetidine during manufacture of solid dosage forms
2. Micelle formation in aqueous and non-aqueous solutions
3. Sodium lauryl sulfate
4. Influence of viscosity and solubilization on dissolution rate
5. Structural aspects of polymorphism
6. Hydrogen bonds in the cimetidine molecule
7. 2-receptor antagonist, in healthy man
8. Comparison of ionic and non-ionic detergents
9. Mechanisms of solid-state reactions of drugs
10. Polymorphic transformation of some drugs under compression
11. Enhancement of dissolution rates of poorly water-soluble drugs by crystallization in aqueous surfactant solutions I: Sulfathiazole, prednisone, and chloramphenicol
12. Characterisation of polyethylene glycols using solution calorimetry
13. Characterisation of polyethylene glycol solid dispersions using differential scanning calorimetry and solution calorimetry
14. Drug solubilization in surfactant systems
15. Discontinuous absorption property of cimetidine
16. Use of solution calorimetry to determine the extent of crystallinity of drugs and excipients
17. Effect of compressional forces on piroxicam polymorphs
18. Theory and origin of polymorphism
19. A disruption index for quantifying the solid state disorder induced by additives or impurities. II. Evaluation from heat of solution
20. Using solution calorimetry to quantitate binary mixtures of three crystalline forms of sulfamethoxazole
21. Pharmaceutical applications of polymorphism
22. The polymorphism of cimetidine
23. Characterization of calcium fenoprofen. I. Powder dissolution rate and degree of crystallinity
24. Polymorphism and drug availability. Solubility relationships in the methylprednisolone system
25. Polymorphism of phenylbutazone: Properties and compressional behavior of crystals
26. Dissolution behavior and bioavailability of cimetidine-HCl (cimetidne monohydrochloride monohydrate)
27. Bioavailability and inhibitory effect for stress ulcer of cimetidine polymorphs in rats
28. The identification and characterization of polymorphism in drug solids by solution calorimetry
29. The physical and chemical problems inherent in the formulation of dosage forms for new pharmaceuticals
30. Slower dissolution rates of sulphamerazine in aqueous sodium dodecyl sulphate solutions than in water
31. Effects of temperature and pressure during compression on polymorphic transformation and crushing strength of chlorpropamide tablets
32. Physicochemical characterization of the various solid forms of carbovir, an antiviral nucleoside
33. Effects of environmental temperature and compression energy on polymorphic transformation during tabletting
34. Relation between polymorphic transformation pathway during grinding and the physicochemical properties of bulk powders for pharmaceutical preparations
35. Polymorphism of indomethacin. Part I. Preparation of polymorphic forms of indomethacin
36. Quantitative crystallinity determinations for β-lactam antibiotics by solution calorimetry: Correlations with stability
37. Effects of grinding and compression on crystal structure of anhydrous caffeine
38. Inhibition of food-stimulated gastric acid secretion by cimetidine
39. Some correlating principles of detergent action
40. Study of crystalline forms of N-cyano-N′-methyl-N″-{2{[(4-methyl-1H-imidazol-5-yl)methyl] thio}ethyl}guanidine (cimetidine)
41. X-ray structural studies and physicochemical properties of cimetidine polymorphism
42. Dissolution of hydrocortisone
43. Precipitation of calcium gluceptate from aqueous solutions
44. Evaluation of two concepts of crystallinity using calcium gluceptate as a model compound
45. Polymorphism of fostedil: Characterization and polymorphic change by mechanical treatments
46. Characterization of the crystallinity of drugs; B02669, a case study
47. The applications of near-infrared Fourier transform Raman spectroscopy to the analysis of polymorphic forms of cimetidine
48. Dissolution study of spiramycin: Influence of agitation intensity and addition of several substances to the dissolution medium
49. CMC of polysorbates